Advent Life Sciences is a leading trans-Atlantic venture capital firm focused on building innovative Life Sciences businesses. They invest in early and mid-stage companies with a first-in-class or best-in-class approach, turning breakthrough science into approved medicines or medical products. The firm takes a hands-on approach, working closely with management teams to achieve superior financial returns.

TempoCap is a key player in the venture and growth capital ecosystem, investing in transformational technology businesses across Europe. They work closely with founders to support their ambitions, providing primary growth capital or secondary acquisitions to support growth.

redalpine is a thesis-driven venture capital firm with deep expertise in software and science. They invest across Europe and focus on empowering game changers, co-creating a better tomorrow with their portfolio companies.

Dawn Capital is a venture capital firm focused on B2B software companies in Europe. They partner with founders to build category-defining companies, providing support and expertise throughout their growth journey.

Endeit Capital is a growth capital firm fueling internationalization and innovation. They invest in innovative tech scale-ups in Europe, focusing on AI and related sectors. The firm emphasizes a hands-on approach and building strong relationships with entrepreneurs.

BioGeneration Ventures is a venture capital firm specializing in seed investments for innovative early-stage life sciences companies in Europe. They often act as lead investors and leverage their extensive industry network to accelerate product development. Their portfolio includes biotech companies developing disruptive solutions for high unmet medical needs.

83North is a global venture capital firm with over $2.2B under management. The fund invests across all stages in exceptional entrepreneurs building global category-leading companies. They have a unique approach to helping companies scale.

HOWZAT Partners is an investment fund focused on early-stage digital businesses with a demonstrable track record. They are selective in their investments, seeking companies with significant potential and a 'HOWZAT' factor – signifying a breakthrough moment. The firm aims to add value and provide support beyond capital.

Forbion invests in life sciences companies in drug development and MedTech. They focus on addressing high medical needs and building breakthrough therapies.

Atomico is a founder-built European venture capital firm investing in innovative technology companies globally. They partner with ambitious entrepreneurs building technology for positive transformation, providing more than just capital but also operational experience and guidance for conscious scaling.

IQ Capital is a deep tech venture capital firm with over 20 years of experience. They invest in companies with defensible IP, breakthrough technologies, and global ambitions, supporting founders from seed to growth. Their focus is on disruptive Deep Tech companies capable of dominating their global markets.

Thuja manages several venture capital funds aimed at building and scaling companies with a prime focus on therapeutics and medical devices. They invest in healthcare innovation, from start-up to scale-up, supporting the development of novel therapies in areas of high unmet medical need.